Morgan Stanley
-
-
-
-
-
-
-
Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Akero Therapeutics (AKRO) Announces Pricing of Public Offering of Common Stock
-
-
-
-
-
-
-
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Akero Therapeutics Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Akero Therapeutics (AKRO) Prices 5.228M Share Common Offering at $36/Sh
-
-
-
-
-
218,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

